Total pleural coverage followed by lung transplantation in patient with lymphangioleiomyomatosis
General Thoracic and Cardiovascular Surgery (2020) 68:1208–1211
https://doi.org/10.1007/s11748-019-01217-0
CASE REPORT
Total pleural coverage followed by lung transplantation in patient
with lymphangioleiomyomatosis
Do Hyung Kim1 · Hyo Yeong Ahn2
· Bong Soo Son1 · Joohyung Son1
Received: 30 May 2019 / Accepted: 21 September 2019 / Published online: 14 October 2019
© The Author(s) 2019
Abstract
Tuberous sclerosis complex lymphangioleiomyomatosis (TSC-LAM) is a rare disease, which may develop an intractable
pneumothorax. Chemical or mechanical pleurodesis is a general management to prevent recurrence of pneumothorax, rendering it difficult to later dissect the pleura and control intraoperative bleeding. Since total pleural coverage (TPC) alternative
to pleurodesis has been firstly reported by Kurihara et al. (Jpn J Thorac Cardiovasc Surg 54:274, 2006), TPC was performed
in case of a 46-year-old female with a secondary spontaneous pneumothorax caused by TSC-LAM and followed by lung
transplantation. Final pathological report showed the reinforced visceral pleura in the absence of dense adhesions.
Keywords Pneumothorax · Lymphangioleiomyomatosis · Lung transplantation
Introduction
Case report
Tuberous sclerosis complex lymphangioleiomyomatosis
(TSC-LAM) is a rare disease, which may trigger an intractable pneumothorax. Chemical or mechanical pleurodesis is
recommended to prevent recurrence, rendering it difficult to
later dissect the pleura and control intraoperative bleeding.
We performed total pleural coverage (TPC) as an alternative to pleurodesis, based on the recommendations of recent
reports. Pathological findings are important when evaluating the efficacy of TPC. Herein, we report the case of a
46-year-old female with a secondary spontaneous pneumothorax caused by TSC-LAM who underwent TPC prior to
lung transplantation.
A 46-year-old female was admitted to the emergency room
with dyspnea, and right pneumothorax was diagnosed. Chest
computed tomography (CT) revealed the features of lymphangioleiomyomatosis (LAM), including facial angiofibroma, hypomelanotic macules, and renal angiomyolipoma;
we thus diagnosed tuberous sclerosis complex (TSC)-LAM.
As the air leakage had developed 10 days prior, airleak control was performed by video-assisted thoracoscopic surgery
(VATS), which showed multiple lung cysts with ruptured
bullae surrounded by a dense adhesion in the right upper
lobe. After releasing the adhesion, the bullae was ligated,
and covered a huge fragile cyst at risk of imminent rupture with an absorbable polyglycolic acid sheet (Neoveil;
Gunze Ltd., Kyoto, Japan) and fibrin sealant (Tisseel; Baxter
Healthcare Corp., Deerfield, IL, USA). To prevent recurrence, we performed total pleural coverage (TPC) of the
entire lung surface using 12 sheets of oxidized regenerated
cellulose (ORC) mesh (Ethicon SURGICEL ® absorbable
Hemostat gauze, Johnson & Johnson, Brunswick, NJ, USA)
(Fig. 1). The patient was discharged on postoperative day
(POD) 9.
One month later, she was readmitted to treat a contralateral recurrent pneumothorax. She again underwent TPC
after ligation of the ruptured bullae and was discharged on
POD 22. Home oxygen therapy and sirolimus 1 mg daily
* Hyo Yeong Ahn
1
Department of Thoracic and Cardiovascular Surgery,
Pusan National University Yangsan Hospital, Gyeongnam,
South Korea
2
Department of Thoracic and Cardiovascular Surgery, Medical
Research Institution, Pusan National University Hospital,
305, Gudeok‑Ro, Seo‑Gu, Busan 602‑739, South Korea
13
Vol:.(1234567890)
General Thoracic and Cardiovascular Surgery (2020) 68:1208–1211
1209
Fig. 1 Gross findings of lungs correlated to computed tomographic
images. a Ruptured bullae were evident in the right upper lobe, as
was a dense adhesion around the bullae. The adhesion was released
and the bullae loop ligated. b The ruptured area (asterisk) contained
bullae, as revealed by CT. c A huge fragile cyst at risk of immediate
rupture was covered by an absorbable polyglycolic acid sheet (e). d
The fragile cyst (arrow) was located near the bullae, as revealed by
CT. f We performed total pleural coverage (TPC) of the entire lung
was prescribed, because the dyspnea remained aggravated
even after operation.
Fourteen months later, lung transplantation was successfully performed; both lungs that had been subjected
to TPC were sampled, revealing thickened visceral pleura
surrounded by minimal inflammation (Fig. 2). After the
operation, oxygen therapy was no longer necessary and
she was discharged on POD 41 without any complication.
Discussion
Tuberous sclerosis complex (TSC) is an autosomal-dominant genetic disorder affecting multiple organs. LAM is
one manifestation of TSC, caused by a TSC2 mutation
triggering aberrant cell proliferation [2].
Since recurrent pneumothorax is one of the most common
complications seen in LAM patients, chemical or mechanical
13
1210
Fig. 2 Gross and microscopic findings of lungs that had undergone
TPC. a, b The surfaces of both the right (a) and left (b) lungs were
relatively smooth. c, d The visceral pleura that had undergone TPC
13
General Thoracic and Cardiovascular Surgery (2020) 68:1208–1211
were thickened, and minimal adhesion of the visceral to the parietal
pleura was evident. e Elastica-Masson stain showed the thickened visceral pleura above the natural visceral pleura (arrow)
General Thoracic and Cardiovascular Surgery (2020) 68:1208–1211
pleurodesis has been recommended to prevent recurrence [3,
4]. However, after pleurodesis, it was difficult to dissect the
pleura and control intraoperative bleeding, because of severe
adhesion. Therefore, TPC was recommended as an alternative to pleurodesis, in which ORC was used to cover the
entire pleura to make thickened visceral pleura, as in studies
of Noda et al., Kurihara et al., Kusu et al. [3, 5–7].
Although sirolimus inhibits tissue proliferation and
the release of lymphangiogenic growth factors [8, 9], and
relieves symptoms, the dyspnea worsened in our case as disease progressed, and lung transplantation was performed at
15 months after the initial operation. The pathology showed
the thickened pleura without severe inflammation (Fig. 2).
Although animal experiments have been performed to
check adhesion or visceral pleural thickness after pleurodesis [3], no report on a patient treated via TPC who later
underwent lung transplantation has appeared. As shown
here, TPC might be one of the good tools for prevention
of recurred pneumothorax, making the thickened visceral
pleura useful to describe our patient with LAM who underwent TPC followed by lung transplantation; examination of
the extracted lung showed that our treatment reinforced the
visceral pleura in the absence of dense adhesions.
Conclusion
TSC-LAM is a rare disease, which may trigger an intractable pneumothorax. TPC might be one of the good tools for
prevention of recurred pneumothorax, making the thickened
visceral pleura useful to describe our (...truncated)